Skip to main content

Table 2 Dose-volume histograms (DVHs) statistics for the gross tumor volume of primary tumor (GTV-P) in patients with locally recurrent NPC

From: Biological target volume based on fluorine-18-fluorode-oxyglucose positron emission tomography/computed tomography imaging: a spurious proposition?

No

Stage

HI

V95%

V100%

V110%

Dmax (Gy)

Dmean (Gy)

Dmin (Gy)

1

T2NT1M0 II

0.09

0.09

94.48

0.00

76.66

73.09

64.06

2

T2N2MO III

0.06

0.01

91.04

0.00

75.21

71.73

66.4

3

T1NT1M0 II

0.03

0.00

99.95

0.00

75.43

72.66

67.89

4

T3N1M0 III

0.09

0.62

95.72

0.00

76.81

72.98

62.95

5

T2N2M0 III

0.06

2.01

88.87

0.00

74.03

71.47

67.05

6

T4N1M0 IV

0.09

0.22

92.14

0.14

77.77

72.2

59.09

7

T4N2M0 IV

0.10

1.32

89.71

0.00

76.61

72.01

56.33

8

T1N2M0 III

0.08

0.01

91.02

0.00

75.82

71.99

66.42

9

T4N1M0 IV

0.09

0.11

97.30

0.68

78.38

73.19

64.48

10

T4N2M0 IV

0.14

2.52

87.98

0.21

77.74

72.73

62.57

11

T2NT0M0 II

0.09

0.02

95.01

0.00

76.19

73.08

66.25

12

T4N1M0 IV

0.09

0.25

97.09

0.00

76.97

73.34

55.09

13

T4N2M0 IV

0.05

0.25

98.55

0.00

76.64

72.69

55.71

14

T3N1M0 III

0.02

0.00

100.00

0.00

73.6

72.09

69.01

15

T3N2M0 III

0.05

0.04

95.55

0.00

74.31

72.19

65.56

16

T1N3M0 IV

0.03

0.00

98.01

0.00

72.69

71.4

69.38

17

T4N1M0 IV

0.04

0.07

98.71

0.00

75.08

71.38

61.7

18

T1N2MO III

0.10

0.21

95.82

0.92

77.83

73.01

65.13

19

T3N2MO III

0.07

0.00

95.75

0.02

77.18

73.17

63.8

20

T3N1M0 III

0.09

0.03

90.39

0.00

75.96

72.23

65.25

21

T3N1MO III

0.06

0.00

98.86

0.00

75.21

72.76

67.73

22

T2N2MO III

0.06

0.00

99.70

0.01

77.92

72.76

68.01

23

T3N3M0 IV

0.07

0.00

99.72

0.28

77.74

74.16

67.74

24

T2N2M0 III

0.08

0.24

94.03

0.00

75.86

72.48

57.93

25

T3N1M0 III

0.08

0.00

97.20

0.04

77.42

73.09

64.66

26

T3N3M0 IV

0.06

0.00

95.82

0.01

77.32

72.17

66.29

27

T3N2M0 III

0.02

0.00

96.90

0.00

72.45

70.85

67.01

28

T3N1M0 III

0.08

0.00

97.30

0.00

77.56

73.43

68.95

29

T1N3M0 IV

0.06

1.09

100.00

0.00

71.45

69.34

59.34

30

T4N2M0 IV

0.08

1.79

96.78

0.07

74.38

73.67

63.81

31

T4N1M0 IV

0.05

0.25

97.93

0.00

76.21

72.02

62.52

32

T4N2M0 IV

0.07

1.36

94.43

0.00

75.88

72.21

64.75

33

T4N0M0 IV

0.06

0.39

97.66

0.00

75.42

72.4

55.34

  1. HI Homogeneity index, V95% = %Volume receiving < 95% of the prescribed dose, V100% = % Volume receiving > 100% of the prescribed dose; V110% = % volume receiving > 110% of the prescribed dose, Dmax Maximum dose, Dmean Mean dose, Dmin Minimum dose